Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 336, pseudogene (RN7SL336P) is a non-protein coding pseudogene belonging to a large family of 7SL pseudogenes in human DNA. These pseudogenes are truncated reverse-transcribed genomic copies of the 7SL RNA—the noncoding RNA component of the signal recognition particle (SRP), an essential ribonucleoprotein complex for co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum[1][2][4][5]. While a small number of 7SL genes are functional and encode the SRP RNA, the vast majority, including RN7SL336P, are unexpressed or non-functional, lacking coding capacity and independently known biological activity. These pseudogenes are products of ancient genomic retrotransposition events and generally do not participate in cellular signaling or disease processes. The 7SL pseudogene family is notable mainly for illustrating the genomic diversity and mobility of noncoding RNA elements rather than serving as active therapeutic or biomarker targets[1][2][4][5]. Summary: RN7SL336P is a processed pseudogene, not a therapeutic target, and there is no evidence of any functional or disease-related role for this locus. The entry may be considered incorrect as a pharmacological target, strictly speaking, because it is not a protein, receptor, enzyme, transporter, or other druggable molecular species[1][2][4][5].
None known (pseudogene, not a druggable target).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 336, pseudogene (RN7SL336P).